Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia

Ikaros deletions are associated with certain human malignancies. Georgopoulos and colleagues show that loss of Ikaros arrests B lymphoid progenitors at an adherent and proliferative pre-B cell stage from which leukemia can arise. Deletion of the DNA-binding domain of the transcription factor Ikaros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature immunology 2014-03, Vol.15 (3), p.294-304
Hauptverfasser: Joshi, Ila, Yoshida, Toshimi, Jena, Nilamani, Qi, Xiaoqing, Zhang, Jiangwen, Van Etten, Richard A, Georgopoulos, Katia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ikaros deletions are associated with certain human malignancies. Georgopoulos and colleagues show that loss of Ikaros arrests B lymphoid progenitors at an adherent and proliferative pre-B cell stage from which leukemia can arise. Deletion of the DNA-binding domain of the transcription factor Ikaros generates dominant-negative isoforms that interfere with its activity and correlate with poor prognosis in human precursor B cell acute lymphoblastic leukemia (B-ALL). Here we found that conditional inactivation of the Ikaros DNA-binding domain in early pre-B cells arrested their differentiation at a stage at which integrin-dependent adhesion to niches augmented signaling via mitogen-activated protein kinases, proliferation and self-renewal and attenuated signaling via the pre-B cell signaling complex (pre-BCR) and the differentiation of pre-B cells. Transplantation of polyclonal Ikaros-mutant pre-B cells resulted in long-latency oligoclonal pre-B-ALL, which demonstrates that loss of Ikaros contributes to multistep B cell leukemogenesis. Our results explain how normal pre-B cells transit from a highly proliferative and stroma-dependent phase to a stroma-independent phase during which differentiation is enabled, and suggest potential therapeutic strategies for Ikaros-mutant B-ALL.
ISSN:1529-2908
1529-2916
DOI:10.1038/ni.2821